These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10687328)

  • 21. A pilot study on the efficacy of ketorolac plus tramadol infusion combined with erythrocytapheresis in the management of acute severe vaso-occlusive crises and sickle cell pain.
    de Franceschi L; Finco G; Vassanelli A; Zaia B; Ischia S; Corrocher R
    Haematologica; 2004 Nov; 89(11):1389-91. PubMed ID: 15531461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies.
    Dampier CD; Smith WR; Wager CG; Kim HY; Bell MC; Miller ST; Weiner DL; Minniti CP; Krishnamurti L; Ataga KI; Eckman JR; Hsu LL; McClish D; McKinlay SM; Molokie R; Osunkwo I; Smith-Whitley K; Telen MJ;
    Clin Trials; 2013 Apr; 10(2):319-31. PubMed ID: 23539110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient characteristics affect the response to ketamine and opioids during the treatment of vaso-occlusive episode-related pain in sickle cell disease.
    Nobrega R; Sheehy KA; Lippold C; Rice AL; Finkel JC; Quezado ZMN
    Pediatr Res; 2018 Feb; 83(2):445-454. PubMed ID: 28902183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
    Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
    Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Parenteral Opioid Dosing in Adult Sickle Cell Disease Patients With Vaso-occlusive Crisis.
    Shah SP; Twilla JD; Kemp L; Phelps GL; Reaves A
    J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):201-207. PubMed ID: 30896312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of ketorolac continuous infusion for multimodal analgesia of vaso-occlusive crisis in patients with sickle cell disease.
    Pinto VM; Gianesin B; Sardo S; Mazzi F; Baiardi G; Menotti S; Piras F; Quintino S; Robello G; Mattioli F; Finco G; Forni GL; De Franceschi L
    Orphanet J Rare Dis; 2024 Jan; 19(1):22. PubMed ID: 38254184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intranasal fentanyl for initial treatment of vaso-occlusive crisis in sickle cell disease.
    Fein DM; Avner JR; Scharbach K; Manwani D; Khine H
    Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27862905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional anesthesia for sickle cell disease vaso-occlusive crisis: A single-center case series.
    Karsenty C; Tubman VN; Liu CJ; Fasipe T; Wyatt KEK
    Pediatr Blood Cancer; 2022 Jun; 69(6):e29695. PubMed ID: 35373913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lactate Dehydrogenase: A Marker of the Severity of Vaso-Occlusive Crisis in Children with Sickle Cell Disease Presenting at the Emergency Department.
    García-Morin M; López-Sangüos C; Vázquez P; Alvárez T; Marañón R; Huerta J; Cela E
    Hemoglobin; 2016 Nov; 40(6):388-391. PubMed ID: 28361592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of two regimens of patient-controlled analgesia for children with sickle cell disease.
    Trentadue NO; Kachoyeanos MK; Lea G
    J Pediatr Nurs; 1998 Feb; 13(1):15-9. PubMed ID: 9503762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multimodal pain protocol for treatment of vaso-occlusive crisis in patients with sickle cell disease: Implementation and evaluation.
    Admiraal M; van Daalen J; Ritt MWJ; Dekker J; van Tuijn CFJ; Nur E; Hollmann MW; Hermanns H; Hermanides J; Biemond BJ
    Eur J Haematol; 2023 Sep; 111(3):382-390. PubMed ID: 37277324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of vaso-occlusive pain in children with sickle cell disease.
    Jacob E; Miaskowski C; Savedra M; Beyer JE; Treadwell M; Styles L
    J Pediatr Hematol Oncol; 2003 Apr; 25(4):307-11. PubMed ID: 12679645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in intensity, location, and quality of vaso-occlusive pain in children with sickle cell disease.
    Jacob E; Miaskowski C; Savedra M; Beyer JE; Treadwell M; Styles L
    Pain; 2003 Mar; 102(1-2):187-93. PubMed ID: 12620610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
    Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
    Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subdissociative intranasal ketamine plus standard pain therapy versus standard pain therapy in the treatment of paediatric sickle cell disease vaso-occlusive crises in resource-limited settings: study protocol for a randomised controlled trial.
    Young JR; Sawe HR; Mfinanga JA; Nshom E; Helm E; Moore CG; Runyon MS; Reynolds SL
    BMJ Open; 2017 Jul; 7(7):e017190. PubMed ID: 28698351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pain Control for Sickle Cell Crisis, a Novel Approach? A Retrospective Study.
    Rollé A; Vidal E; Laguette P; Garnier Y; Delta D; Martino F; Portecop P; Etienne-Julan M; Piednoir P; De Jong A; Romana M; Bernit E
    Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138299
    [No Abstract]   [Full Text] [Related]  

  • 37. A chronology of pain and comfort in children with sickle cell disease.
    Beyer JE; Simmons LE; Woods GM; Woods PM
    Arch Pediatr Adolesc Med; 1999 Sep; 153(9):913-20. PubMed ID: 10482205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analgesic efficacy of topical lidocaine for vaso-occlusive crisis in children with sickle cell disease].
    Rasolofo J; Poncelet M; Rousseau V; Marec-Berard P
    Arch Pediatr; 2013 Jul; 20(7):762-7. PubMed ID: 23731603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful epidural analgesia for a vaso-occlusive crisis of sickle cell disease during pregnancy: a case report.
    Verstraete S; Verstraete R
    J Anesth; 2012 Oct; 26(5):783-5. PubMed ID: 22573004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.
    Hoppe CC; Styles L; Heath LE; Zhou C; Jakubowski JA; Winters KJ; Brown PB; Rees DC; Heeney MM
    Pediatr Blood Cancer; 2016 Feb; 63(2):299-305. PubMed ID: 26402148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.